Skip to main content

Table 4 Univariate analysis of risk factors and adverse patient outcomes

From: Investigating the clinical significance of body composition changes in patients undergoing chemoradiation for oropharyngeal cancer using analytic morphomics

Measure

P value

HR (95 % CI)

(A) Tumor recurrence

  

 Total psoas area (% decline)

0.019

1.117 (1.018–1.225)

 Weight (% decline)

0.163

1.064 (0.975–1.160)

 Age

0.43

0.961 (0.871–1.061)

 T-stage

0.043

2.048 (1.024–4.095)

 Lean psoas area (% decline)

0.14

1.047 (0.985–1.114)

 Psoas HU (% decline)

0.933

0.988 (0.957–1.041)

(B) Mortality

  

 Total psoas area (% decline)

0.043

1.127 (1.004–1.266)

 Weight (% decline)

0.047

1.111 (1.001–1.233)

 Age

0.0514

1.037 (0.929–1.157)

 T-stage

0.028

3.891 (1.161–13.046)

 Lean psoas area (% decline)

0.147

1.060 (0.980–1.148)

 Psoas HU (% decline)

0.656

1.010 (0.966–1.057)